May 11, 2020
HKBU-led Research Team Develops Novel Anti-viral Targeted Drug for Nasopharyngeal Cancer Treatment
Mar 26, 2020
Impact Health offers COVID-19 Rapid Ten Minute Test Kit and Services
Dec 09, 2019
Researchers at John Theurer Cancer Center, a Member of the Georgetown Lombardi Comprehensive Cancer Center Consortium, Participated in 46 Studies Presented at the 2019 American Society of Hematology's Annual Meeting & Exposition
Dec 08, 2019
Viracta Announces Positive Phase 1b/2 Data Presented at Oral Presentation on Lead Program for Epstein-Barr Virus (EBV)-associated Relapsed/Refractory Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Nov 06, 2019
Viracta Announces Oral Presentation on Lead Program for EBV-associated Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting
Oct 28, 2019
Viracta Therapeutics Announces Closing of Series D Preferred Stock Financing
Jun 03, 2019
Viracta Presents New Clinical Results on Lead Epigenetic Drug Candidate for EBV-Associated Lymphomas at the 2019 ASCO Annual Meeting
May 15, 2019
Viracta to Present New Clinical Results on Lead Epigenetic Drug Candidate Nanatinostat at the 2019 ASCO Annual Meeting
Apr 16, 2019
Viracta Receives Orphan Drug Designation from the US FDA for its Lead Epigenetic Drug Candidate Nanatinostat for EBV-Associated Cancers
Dec 20, 2018
Want to Prevent Cancer? Decrease the Number of Latent Viruses in Your Body; The CBCD Announces the Publication of a New Research Paper in the Medical Journal Oncotarget
Nov 21, 2018
Sheppard Pratt Health System Research Shows Schizophrenia is Associated with Abnormal Immune Response to Epstein-Barr Virus
Apr 16, 2018
'Mono' Virus Linked to Seven Serious Diseases
Feb 13, 2018
MediPoint: HPV and EBV Tests - Global Analysis and Market Forecasts